Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Nuclear Medicine
|
April 26, 2020
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CT
Nicolas Plouznikoff, Carlos Artigas, Erwin Woff, et al.
Clinical Nuclear Medicine
|
July 6, 2019
Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer
Nicolas Plouznikoff, Erwin Woff, Carlos Artigas, et al.
European Journal of Case Reports in Internal Medicine
|
March 26, 2021
Sarcoidosis Versus Lymphoma?
Lissandra Dal Lago, Julie Sarrand, Erwin Woff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2025
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma
Wendy Delbart, Ioannis Karfis, Marie Vercruyssen, et al.
EJNMMI Reports
|
July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myeloma
Wendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
Erwin Woff, Lisa Salvatore, Federica Marmorino, et al.
Clinical Nuclear Medicine
|
June 29, 2023
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel
Qaid Ahmed Shagera, Ioannis Karfis, Spyridon Sideris, et al.
JCO Clinical Cancer Informatics
|
April 30, 2025
Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer
Zelda Paquier, Jennifer Dhont, Thomas Guiot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Nuclear Medicine
|
April 26, 2020
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CT
Nicolas Plouznikoff, Carlos Artigas, Erwin Woff, et al.
Clinical Nuclear Medicine
|
July 6, 2019
Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer
Nicolas Plouznikoff, Erwin Woff, Carlos Artigas, et al.
European Journal of Case Reports in Internal Medicine
|
March 26, 2021
Sarcoidosis Versus Lymphoma?
Lissandra Dal Lago, Julie Sarrand, Erwin Woff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2025
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma
Wendy Delbart, Ioannis Karfis, Marie Vercruyssen, et al.
EJNMMI Reports
|
July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myeloma
Wendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
Erwin Woff, Lisa Salvatore, Federica Marmorino, et al.
Clinical Nuclear Medicine
|
June 29, 2023
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel
Qaid Ahmed Shagera, Ioannis Karfis, Spyridon Sideris, et al.
JCO Clinical Cancer Informatics
|
April 30, 2025
Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer
Zelda Paquier, Jennifer Dhont, Thomas Guiot, et al.
Page
of 2